RWD-derived response in multiple myeloma

por Xu, Tao, Roose, James, Williamson, Mellissa, Sawas, Ahmed, Hong, Wan-Jen, Jin, Huan, Maignan, Kathleen, Rocci, Alberto, Yousefi, Kasra, Kumar, Shaji, Tyanova, Stefka
Publicado 2023

Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis

por Lee, Hak J, Yousefi, Kasra, Haddad, Zaid, Abdollah, Firas, Lam, Lucia LC, Shin, Heesun, Alshalalfa, Mohammed, Godebu, Elana, Wang, Song, Shabaik, Ahmed, Davicioni, Elai, Kane, Christopher J
Publicado 2016

Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome

por Gerds, Aaron T., Scott, Bart L., Greenberg, Peter, Lin, Tara L., Pollyea, Daniel A., Verma, Amit, Dail, Monique, Feng, Yuning, Green, Cherie, Ma, Connie, Medeiros, Bruno C., Yan, Mark, Yousefi, Kasra, Donnellan, William
Publicado 2022

Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy

por Faraj, Sheila F., Bezerra, Stephania M., Yousefi, Kasra, Fedor, Helen, Glavaris, Stephanie, Han, Misop, Partin, Alan W., Humphreys, Elizabeth, Tosoian, Jeffrey, Johnson, Michael H., Davicioni, Elai, Trock, Bruce J., Schaeffer, Edward M., Ross, Ashley E., Netto, George J.
Publicado 2016

Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy

por Den, Robert B., Feng, Felix Y., Showalter, Timothy N., Mishra, Mark V., Trabulsi, Edouard J., Lallas, Costas D., Gomella, Leonard G., Kelly, W. Kevin, Birbe, Ruth C., McCue, Peter A., Ghadessi, Mercedeh, Yousefi, Kasra, Davicioni, Elai, Knudsen, Karen E., Dicker, Adam P.
Publicado 2014

Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma

por Patra-Kneuer, Maria, Chang, Gaomei, Xu, Wendan, Augsberger, Christian, Grau, Michael, Zapukhlyak, Myroslav, Ilieva, Kristina, Landgraf, Karin, Mangelberger-Eberl, Doris, Yousefi, Kasra, Berning, Philipp, Kurz, Katrin S., Ott, German, Klener, Pavel, Khandanpour, Cyrus, Horna, Pedro, Schanzer, Jürgen, Steidl, Stefan, Endell, Jan, Heitmüller, Christina, Lenz, Georg
Publicado 2023

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients

por Alshalalfa, Mohammed, Verhaegh, Gerald W., Gibb, Ewan A., Santiago-Jiménez, Maria, Erho, Nicholas, Jordan, Jennifer, Yousefi, Kasra, Lam, Lucia L.C., Kolisnik, Tyler, Chelissery, Jijumon, Seiler, Roland, Ross, Ashley E., Karnes, R. Jeffrey, Schaeffer, Edward M., Lotan, Tamara T., Den, Robert B., Freedland, Stephen J., Davicioni, Elai, Klein, Eric A., Schalken, Jack A.
Publicado 2017

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO‐IM...

por Gore, John L., du Plessis, Marguerite, Santiago‐Jiménez, María, Yousefi, Kasra, Thompson, Darby J. S., Karsh, Lawrence, Lane, Brian R., Franks, Michael, Chen, David Y. T., Bandyk, Mark, Bianco, Fernando J., Brown, Gordon, Clark, William, Kibel, Adam S., Kim, Hyung L., Lowrance, William, Manoharan, Murugesan, Maroni, Paul, Perrapato, Scott, Sieber, Paul, Trabulsi, Edouard J., Waterhouse, Robert, Davicioni, Elai, Lotan, Yair, Lin, Daniel W.
Publicado 2017